Increased cardiovascular mortality after early bilateral oophorectomy

Cathleen M. Rivera, Brandon R. Grossardt, Deborah Rhodes, Robert D Jr. Brown, Veronique Lee Roger, L. Joseph Melton, Walter A Rocca

Research output: Contribution to journalArticle

241 Citations (Scopus)

Abstract

OBJECTIVE: To investigate the mortality associated with cardiovascular diseases and the effect of estrogen treatment in women who underwent unilateral or bilateral oophorectomy before menopause. DESIGN: We conducted a cohort study with long-term follow-up of women in Olmsted County, MN, who underwent either unilateral or bilateral oophorectomy before the onset of menopause from 1950 through 1987. Each member of the oophorectomy cohort was matched by age to a referent woman from the same population who had not undergone any oophorectomy. We studied the mortality associated with cardiovascular disease in a total of 1,274 women with unilateral oophorectomy, 1,091 women with bilateral oophorectomy, and 2,383 referent women. RESULTS: Women who underwent unilateral oophorectomy experienced a reduced mortality associated with cardiovascular disease compared with referent women (hazard ratio [HR], 0.82; 95% CI, 0.67-0.99; P = 0.04). In contrast, women who underwent bilateral oophorectomy before age 45 years experienced an increased mortality associated with cardiovascular disease compared with referent women (HR, 1.44; 95% CI, 1.01-2.05; P = 0.04). Within this age stratum, the HR for mortality was significantly increased in women who were not treated with estrogen through age 45 years or longer (HR, 1.84; 95% CI, 1.27-2.68; P = 0.001) but not in women treated with estrogen (HR, 0.65; 95% CI, 0.30-1.41; P = 0.28; test of interaction, P = 0.01). Mortality was further increased after deaths associated with cerebrovascular causes were excluded. CONCLUSIONS: Bilateral oophorectomy performed before age 45 years is associated with increased cardiovascular mortality, especially with cardiac mortality. However, estrogen treatment may reduce this risk.

Original languageEnglish (US)
Pages (from-to)15-23
Number of pages9
JournalMenopause
Volume16
Issue number1
DOIs
StatePublished - Jan 2009

Fingerprint

Ovariectomy
Mortality
Estrogens
Cardiovascular Diseases
Menopause
Cohort Studies

Keywords

  • Age at menopause
  • Cardiovascular disease
  • Estrogen treatment
  • Mortality
  • Oophorectomy

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Medicine(all)

Cite this

Increased cardiovascular mortality after early bilateral oophorectomy. / Rivera, Cathleen M.; Grossardt, Brandon R.; Rhodes, Deborah; Brown, Robert D Jr.; Roger, Veronique Lee; Melton, L. Joseph; Rocca, Walter A.

In: Menopause, Vol. 16, No. 1, 01.2009, p. 15-23.

Research output: Contribution to journalArticle

Rivera, Cathleen M. ; Grossardt, Brandon R. ; Rhodes, Deborah ; Brown, Robert D Jr. ; Roger, Veronique Lee ; Melton, L. Joseph ; Rocca, Walter A. / Increased cardiovascular mortality after early bilateral oophorectomy. In: Menopause. 2009 ; Vol. 16, No. 1. pp. 15-23.
@article{d84987ab8bdf481198532ca274b2f108,
title = "Increased cardiovascular mortality after early bilateral oophorectomy",
abstract = "OBJECTIVE: To investigate the mortality associated with cardiovascular diseases and the effect of estrogen treatment in women who underwent unilateral or bilateral oophorectomy before menopause. DESIGN: We conducted a cohort study with long-term follow-up of women in Olmsted County, MN, who underwent either unilateral or bilateral oophorectomy before the onset of menopause from 1950 through 1987. Each member of the oophorectomy cohort was matched by age to a referent woman from the same population who had not undergone any oophorectomy. We studied the mortality associated with cardiovascular disease in a total of 1,274 women with unilateral oophorectomy, 1,091 women with bilateral oophorectomy, and 2,383 referent women. RESULTS: Women who underwent unilateral oophorectomy experienced a reduced mortality associated with cardiovascular disease compared with referent women (hazard ratio [HR], 0.82; 95{\%} CI, 0.67-0.99; P = 0.04). In contrast, women who underwent bilateral oophorectomy before age 45 years experienced an increased mortality associated with cardiovascular disease compared with referent women (HR, 1.44; 95{\%} CI, 1.01-2.05; P = 0.04). Within this age stratum, the HR for mortality was significantly increased in women who were not treated with estrogen through age 45 years or longer (HR, 1.84; 95{\%} CI, 1.27-2.68; P = 0.001) but not in women treated with estrogen (HR, 0.65; 95{\%} CI, 0.30-1.41; P = 0.28; test of interaction, P = 0.01). Mortality was further increased after deaths associated with cerebrovascular causes were excluded. CONCLUSIONS: Bilateral oophorectomy performed before age 45 years is associated with increased cardiovascular mortality, especially with cardiac mortality. However, estrogen treatment may reduce this risk.",
keywords = "Age at menopause, Cardiovascular disease, Estrogen treatment, Mortality, Oophorectomy",
author = "Rivera, {Cathleen M.} and Grossardt, {Brandon R.} and Deborah Rhodes and Brown, {Robert D Jr.} and Roger, {Veronique Lee} and Melton, {L. Joseph} and Rocca, {Walter A}",
year = "2009",
month = "1",
doi = "10.1097/gme.0b013e31818888f7",
language = "English (US)",
volume = "16",
pages = "15--23",
journal = "Menopause",
issn = "1072-3714",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Increased cardiovascular mortality after early bilateral oophorectomy

AU - Rivera, Cathleen M.

AU - Grossardt, Brandon R.

AU - Rhodes, Deborah

AU - Brown, Robert D Jr.

AU - Roger, Veronique Lee

AU - Melton, L. Joseph

AU - Rocca, Walter A

PY - 2009/1

Y1 - 2009/1

N2 - OBJECTIVE: To investigate the mortality associated with cardiovascular diseases and the effect of estrogen treatment in women who underwent unilateral or bilateral oophorectomy before menopause. DESIGN: We conducted a cohort study with long-term follow-up of women in Olmsted County, MN, who underwent either unilateral or bilateral oophorectomy before the onset of menopause from 1950 through 1987. Each member of the oophorectomy cohort was matched by age to a referent woman from the same population who had not undergone any oophorectomy. We studied the mortality associated with cardiovascular disease in a total of 1,274 women with unilateral oophorectomy, 1,091 women with bilateral oophorectomy, and 2,383 referent women. RESULTS: Women who underwent unilateral oophorectomy experienced a reduced mortality associated with cardiovascular disease compared with referent women (hazard ratio [HR], 0.82; 95% CI, 0.67-0.99; P = 0.04). In contrast, women who underwent bilateral oophorectomy before age 45 years experienced an increased mortality associated with cardiovascular disease compared with referent women (HR, 1.44; 95% CI, 1.01-2.05; P = 0.04). Within this age stratum, the HR for mortality was significantly increased in women who were not treated with estrogen through age 45 years or longer (HR, 1.84; 95% CI, 1.27-2.68; P = 0.001) but not in women treated with estrogen (HR, 0.65; 95% CI, 0.30-1.41; P = 0.28; test of interaction, P = 0.01). Mortality was further increased after deaths associated with cerebrovascular causes were excluded. CONCLUSIONS: Bilateral oophorectomy performed before age 45 years is associated with increased cardiovascular mortality, especially with cardiac mortality. However, estrogen treatment may reduce this risk.

AB - OBJECTIVE: To investigate the mortality associated with cardiovascular diseases and the effect of estrogen treatment in women who underwent unilateral or bilateral oophorectomy before menopause. DESIGN: We conducted a cohort study with long-term follow-up of women in Olmsted County, MN, who underwent either unilateral or bilateral oophorectomy before the onset of menopause from 1950 through 1987. Each member of the oophorectomy cohort was matched by age to a referent woman from the same population who had not undergone any oophorectomy. We studied the mortality associated with cardiovascular disease in a total of 1,274 women with unilateral oophorectomy, 1,091 women with bilateral oophorectomy, and 2,383 referent women. RESULTS: Women who underwent unilateral oophorectomy experienced a reduced mortality associated with cardiovascular disease compared with referent women (hazard ratio [HR], 0.82; 95% CI, 0.67-0.99; P = 0.04). In contrast, women who underwent bilateral oophorectomy before age 45 years experienced an increased mortality associated with cardiovascular disease compared with referent women (HR, 1.44; 95% CI, 1.01-2.05; P = 0.04). Within this age stratum, the HR for mortality was significantly increased in women who were not treated with estrogen through age 45 years or longer (HR, 1.84; 95% CI, 1.27-2.68; P = 0.001) but not in women treated with estrogen (HR, 0.65; 95% CI, 0.30-1.41; P = 0.28; test of interaction, P = 0.01). Mortality was further increased after deaths associated with cerebrovascular causes were excluded. CONCLUSIONS: Bilateral oophorectomy performed before age 45 years is associated with increased cardiovascular mortality, especially with cardiac mortality. However, estrogen treatment may reduce this risk.

KW - Age at menopause

KW - Cardiovascular disease

KW - Estrogen treatment

KW - Mortality

KW - Oophorectomy

UR - http://www.scopus.com/inward/record.url?scp=64049116138&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=64049116138&partnerID=8YFLogxK

U2 - 10.1097/gme.0b013e31818888f7

DO - 10.1097/gme.0b013e31818888f7

M3 - Article

C2 - 19034050

AN - SCOPUS:64049116138

VL - 16

SP - 15

EP - 23

JO - Menopause

JF - Menopause

SN - 1072-3714

IS - 1

ER -